Day in the Life of Three UC Patients

This activity is for people who have or know someone who has ulcerative colitis (UC). The goal of this patient education activity is for you to learn about individualized treatment options that minimize steroid use and maximize disease remission and promote improved medication adherence and satisfaction with therapy by encouraging you to engage with your physician for more shared decision-making in your treatment plan.
 
Educational Partner: RedMedEd
 
Medium: Online Interactive Course
Published October 28, 2021
 
Commercial Support: Support for this activity has been provided through educational grants from AbbVie Inc; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

This activity is intended for patients interested in learning about ulcerative colitis treatment.

Learning Objectives

At the conclusion of this activity, patients will learn:

  • Identify available treatment options,
  • Identify various plans for treatment,
  • Navigate the impact of day-to-day symptoms or treatment side effects,
  • Determine when to alert the health care team to side effects experienced with treatment,
  • Identify alternative treatment options with the health care team when current therapy becomes challenging (eg, treatment adherence/compliance).
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
RedMedEd
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
610-251-6841
Summary
Activity opens: 
10/28/2021
Activity expires: 
10/29/2022
FACULTY
  David T. Rubin, MD
  Program Chair
  Joseph B. Kirsner Professor of Medicine
  Section Chief, Gastroenterology, Hepatology and Nutrition
  Co-Director, Digestive Diseases Center
  University of Chicago Medicine
                          Chicago, Illinois
 
  Bincy P. Abraham, MD, MS
  Professor of Clinical Medicine
  Weill-Cornell & Houston Methodist Academic Institute
  Director, Fondren Inflammatory Bowel Disease Program
  Houston Methodist
  Houston, Texas
 
  Ethan Blumenthal
  Patient Advocate
  Chicago, Illinois
 
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

This patient education has been developed through a collaboration between the University of Chicago Medicine and RedMedEd.
Registration: To view this activity, you will need to visit RedMedEd's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.